The First Hospital Affiliated to the Army Medical University
Welcome,         Profile    Billing    Logout  
 9 Trials 
7 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Mao, Qing
NCT04683406: A Study of ZSP1273 Tablets in Patients With Acute Uncomplicated Influenza A

Completed
3
750
RoW
ZSP1273 600 mg, Placebo to Oseltamivir, Oseltamivir(oral), Placebo to ZSP1273
Guangdong Raynovent Biotech Co., Ltd
Influenza A
04/23
05/23
NATiV3, NCT04849728: A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( )

Recruiting
3
1000
Europe, Canada, US, RoW
IVA337, Lanifibranor, Placebo
Inventiva Pharma
NASH - Nonalcoholic Steatohepatitis
09/25
09/26
NCT04449588 / 2020-001671-32: Efficacy and Safety Study of BDB-001 in Severe COVID-19 With ALI/ARDS

Terminated
2/3
369
Europe, RoW
BDB-001 Injection, Conventional treatment
Staidson (Beijing) Biopharmaceuticals Co., Ltd, Beijing Defengrui Biotechnology Co. Ltd
COVID-19 Pneumonia
03/24
03/24
NCT04426968: A Phase II Study of Hepalatide in Subjects With Chronic Hepatitis B

Completed
2
96
RoW
Hepalatide 2.1mg, L47, Hepalatide 4.2mg, Hepalatide 6.3mg, placebo 2.1mg, placebo 4.2mg, placebo 6.3mg, Pegylated Interferon, Pegasys
Shanghai HEP Pharmaceutical Co., Ltd.
Hepatitis B, Chronic
11/23
11/23
NCT06150014: A Clinical Study of TQA3605 Tablets Monotherapy or in Combination With Nucleoside (Acid) Analogues in Treatment Naive and Treated Patients With Chronic Hepatitis B

Active, not recruiting
1/2
88
RoW
Placebo, TQA3605 tablets, Entecavir dispersible tablets, Tenofovir disoproxil fumarate tablet, Tenofovir alafenamide fumarate tablet
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Chronic Hepatitis b
12/25
09/26
NCT06452693: A Clinical Study to Evaluate the Efficacy of TQA3038 Injection in Patients With Chronic Hepatitis B

Not yet recruiting
1/2
162
RoW
TQA3038 injection/placebo, Nucleotide drugs Control group
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Hepatitis B, Chronic
09/26
09/26
NCT06363162: Evaluate the Effectiveness and Safety of Raman IVD Analyzer in the Molecular Diagnosis of Gliomas During Surgery

Recruiting
N/A
200
RoW
Immunohistochemistry or genetic test, Raman analyzer diagnosis
Beijing Tiantan Hospital, West China Hospital, The First Affiliated Hospital of Zhengzhou University, Capital Medical University, Jiangsu Raman Medical Equipment Co., Ltd.
Glioma
06/25
12/25

Download Options